Literature DB >> 9518466

Expression, purification, and characterization of recombinant human interleukin-13 from NS-O cells.

S Cannon-Carlson1, J Varnerin, A Tsarbopoulos, C H Jenh, M A Cox, C C Chou, N Connelly, P Zavodny, J C Tang.   

Abstract

Interleukin-13 is a cytokine which is secreted by activated T lymphocytes and primarily impacts monocytes, macrophages, and B cells. A synthetic gene coding for human interleukin-13 has been prepared and cloned into expression vector pEE12. The construct was transfected into NS-O cells, which showed stable expression of the recombinant protein. A four-step purification procedure consisting of S-Sepharose, Q-Sepharose, hydroxyapatite, and Sephacryl-100 chromatographies yielded bioactive interleukin-13 of > 98% purity. The purified protein was structurally characterized. The extinction coefficient at 280 nm was determined to be 5678 M-1 cm-1. Amino acid sequencing confirmed that the N-terminus of the purified protein was intact. Electrospray mass spectrometric analysis, size-exclusion chromatography, and SDS-PAGE revealed that the biologically active protein is monomeric and unglycosylated. Mass spectrometry and a chemical assay for free sulfhydryls indicated that the four cysteine residues of interleukin-13 are involved in two intramolecular disulfide bonds. The circular dichroism spectrum confirms that interleukin-13 belongs to the alpha-helical family of cytokines. A biologically inactive covalent trimer also forms in the cell culture, but can be separated from the monomer by the hydroxyapatite and size-exclusion chromatographies. These data indicate that human interleukin-13 retains many structural similarities to human interleukin-4, from which it arose by a gene duplication event.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518466     DOI: 10.1006/prep.1997.0835

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Secondary structure and backbone resonance assignments for human interleukin-13.

Authors:  E Z Eisenmesser; D A Horita; R A Byrd
Journal:  J Biomol NMR       Date:  2001-01       Impact factor: 2.835

2.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

Review 3.  Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.

Authors:  Reynald Tremblay; David Wang; Anthony M Jevnikar; Shengwu Ma
Journal:  Biotechnol Adv       Date:  2009-12-02       Impact factor: 14.227

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.